Dana-Farber Faculty Named Among 2026 Boston Magazine Top Doctors™

Overview

Boston magazine has recognized over 145 physicians affiliated with Dana-Farber Cancer Institute as Top Doctors™ in its 2026 annual guide. This distinction highlights Dana-Farber's commitment to excellence across a broad range of oncology and related specialties.

Background

The Boston magazine Top Doctors™ list is derived from the Castle Connolly Medical Ltd. physician database and features leading physicians from the Boston area across multiple specialties. Dana-Farber Cancer Institute, in collaboration with Brigham and Women's Hospital and Boston Children’s Hospital, provides comprehensive adult and pediatric cancer care. The recognition reflects the institute’s dedication to compassionate, innovative, and expert patient care.

Data Highlights

More than 145 Dana-Farber-affiliated physicians were named Top Doctors™ in the February 2026 issue of Boston magazine. These physicians represent diverse specialties including medical oncology, hematology, radiation oncology, surgical oncology, pediatric hematology-oncology, neurology, pathology, and more.

Key Findings

• Over 145 Dana-Farber-affiliated faculty were named to the 2026 Boston magazine Top Doctors™ list.
• The recognized physicians span numerous specialties such as medical oncology, hematology, radiation oncology, surgical oncology, pediatric hematology-oncology, and neurological surgery.
• Dana-Farber’s collaboration with Brigham and Women's Hospital and Boston Children’s Hospital supports comprehensive cancer care for adults and children.
• Dr. Benjamin L. Ebert, Dana-Farber’s president and CEO, emphasized that this recognition reflects the faculty’s commitment to compassionate and cutting-edge care.
• The Top Doctors™ list is based on a reputable physician database maintained by Castle Connolly Medical Ltd., underscoring the high standards of the selected physicians.

Clinical Implications

This extensive recognition of Dana-Farber-affiliated physicians underscores the institute’s role as a leader in cancer care and research. Clinicians can be confident in referring patients to Dana-Farber specialists who are nationally recognized for their expertise. The multidisciplinary nature of the recognized faculty highlights the comprehensive approach to oncology care available at Dana-Farber and its partner hospitals.

Conclusion

The inclusion of more than 145 Dana-Farber-affiliated physicians in Boston magazine’s 2026 Top Doctors™ list affirms the institute’s excellence and leadership in cancer care. This recognition supports Dana-Farber’s mission to provide innovative, compassionate treatment to patients and families.

References

1. Boston Magazine 2026 -- More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™